Blood marker may spot hidden fungal infections in ICU patients
NCT ID NCT03140748
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at whether a substance called β-D-glucan in the blood can help identify and track fungal infections in the abdomen (peritonitis) in intensive care patients. Researchers measured levels in 70 adults with peritonitis, comparing those with and without Candida yeast. The goal was to see if this blood test could aid diagnosis and monitor treatment response.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that measuring β-D-glucan in the blood helps doctors diagnose and monitor fungal peritonitis, potentially improving treatment decisions.
- What could go wrong
- This is a small, observational study with only 70 participants. It does not test a treatment, so it may not lead to any direct patient benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANDIDA INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens Picardie
Amiens, Picardie, 80054, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Baby thrush may predict cavity risk: study investigates link
- Speed test: new PCR method outruns standard lab for abdominal infections
- Massive saudi study aims to improve emergency surgery survival
- One surgery instead of two for candida joint infections?
- ICU fungus study aims to uncover resistance secrets
- New index may predict sepsis death risk